These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 12227720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
    Himmelfarb J.
    Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
    Siems W, Carluccio F, Radenkovic S, Grune T, Hampl H.
    Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
    [Abstract] [Full Text] [Related]

  • 7. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
    Aviram M.
    Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress: an accomplice to uremic toxicity?
    Mircescu G.
    J Ren Nutr; 2006 Jul; 16(3):194-8. PubMed ID: 16825018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
    Stenvinkel P, Diczfalusy U, Lindholm B, Heimbürger O.
    Nephrol Dial Transplant; 2004 Apr; 19(4):972-6. PubMed ID: 15031358
    [Abstract] [Full Text] [Related]

  • 11. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
    Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP.
    Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
    [Abstract] [Full Text] [Related]

  • 12. [Cytokines, metalloproteinases, neopterin and cardiovascular mortality among patients with chronic renal failure].
    Kościów K, Małecki R, Adamiec R.
    Pol Merkur Lekarski; 2007 Jan; 22(127):54-7. PubMed ID: 17477092
    [Abstract] [Full Text] [Related]

  • 13. [Effect of oxidative stress in patients with chronic renal failure].
    González Rico M, Puchades MJ, García Ramón R, Saez G, Tormos MC, Miguel A.
    Nefrologia; 2006 Jan; 26(2):218-25. PubMed ID: 16808260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B, Nofer TW, Wasowicz W.
    Int J Occup Med Environ Health; 2002 Jan; 15(1):19-27. PubMed ID: 12038860
    [Abstract] [Full Text] [Related]

  • 19. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D, Rokach J, Lawson J, FitzGerald GA.
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.